Adagio Medical Holdings (ADGM) Non Operating Interest Expenses (2023 - 2026)

Adagio Medical Holdings has disclosed Non Operating Interest Expenses across 4 years of filings, most recently posting $805000.0 for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses rose 11.81% year-over-year to $805000.0; the TTM figure through Jun 2026 stood at $3.1 million (up 20.57% YoY), while the FY2025 annual figure was $2.9 million, up 162.99% from the prior year.
• Non Operating Interest Expenses came in at $805000.0 for Q2 2026 at Adagio Medical Holdings, up from $778000.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $805000.0 in Q2 2026 to a low of $435000.0 in Q3 2024.
• Average Non Operating Interest Expenses over 4 years is $681818.2, with a median of $749000.0 recorded in 2025.
• The largest YoY upside for Non Operating Interest Expenses was 72.18% in 2025 against a maximum downside of 12.2% in 2025.
• Over 4 years, Non Operating Interest Expenses stood at $577000.0 in 2023, then declined by 24.61% to $435000.0 in 2024, then soared by 78.16% to $775000.0 in 2025, then increased by 3.87% to $805000.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $805000.0 in Q2 2026, $778000.0 in Q1 2026, and $775000.0 in Q4 2025.